One of the new features included in the app, is the ability for customers to unlock merchandise locked up on shelves in ...

Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently undervalued, has posted a ...

CVS's app is designed as a one-stop shop for customers to do everything from manage prescriptions to opening locked display ...

Pharmacies across Oklahoma say they are losing hundreds of thousands of dollars because they say a company, CVS Caremark, is supposed to reimburse them for prescriptions and isn't holding up their end ...

Edward Jones last night upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story” with the potential for ...

Edward Jones has upgraded CVS Health (CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. Read more here.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...